Raman Mehrzad, MD
Plastic Surgery · New Haven, CTNPI 1376806356
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (46.7%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 63.1% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2024 at $2,432 and has fallen 86.7% since, to $324 in 2025.
Across 45 payments — averaging $70.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Stryker$361
- Revance Therapeutics, Inc.$279
- Mentor Worldwide LLC$151
- Axogen$103
- Motiva USA, LLC$75
- plus $210 from 4 others
What the payments were for
- Travel & lodging$1,48947%
- Food & beverage$1,46846%
- Education$2357%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 16 | $2,014 |
| Stryker | 4 | $361 |
| Revance Therapeutics, Inc. | 6 | $279 |
| Mentor Worldwide LLC | 6 | $151 |
| Axogen | 2 | $103 |
| Motiva USA, LLC | 2 | $75 |
| Solta Medical, A Division Of Bausch Health US, LLC | 4 | $72 |
| Pacira Pharmaceuticals Incorporated | 3 | $69 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $38 |
| Conmed Corporation | 1 | $30 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,192 in reported general payments places this provider in the 70th percentile of 62 plastic surgery providers in Connecticut.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 11 | $3,393 |
| EliquisApixaban | 12 | $3,105 |
| XareltoRivaroxaban | 11 | $2,629 |
| Metoprolol Succinate | 13 | $335 |
| Sertraline Hcl | 13 | $289 |
| Furosemide | 13 | $169 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in New Haven
- Michael AlperovichNew Haven$78K
- Siba HaykalNew Haven$45K
- Angie PaikNew Haven$5K
- Bohdan PomahacNew Haven$2K
- Kerry MorrisonNew Haven$749
- Alyssa RainesNew Haven$456
- Nayif AlnaifNew Haven$155
- Tormod WestvikNew Haven$125
- Derek SteinbacherGuilford$59K
- Wilfred BrownMiddlebury$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.